Stage-specific digital health technology biomarkers enhance diagnostic and early progression detection in Parkinson’s disease - Report - MDSpire

Stage-specific digital health technology biomarkers enhance diagnostic and early progression detection in Parkinson’s disease

  • By

  • Matthew D. Czech

  • Samantha Sawicki

  • Cindy Zadikoff

  • Chengcheng Liu

  • Weining Robieson

  • Ying Liu

  • Weihua Shi

  • Jie Shen

  • Michelle Crouthamel

  • Maria S. Quinton

  • Josh Cosman

  • E. Ray Dorsey

  • Jamie L. Adams

  • Naomi Nevler

  • July 8, 2026

  • 0 min

Share

Clinical Report: Digital Health Technology Biomarkers in Parkinson’s Disease

Overview

This study evaluates the effectiveness of digital health technology (DHT) measures in diagnosing early-stage Parkinson's disease (PD) and monitoring disease progression. Findings indicate that disease-stage specific feature sets enhance sensitivity in distinguishing PD from healthy controls and tracking short-term changes.

Background

The absence of approved disease-modifying treatments for early Parkinson's disease (ePD) highlights the need for reliable diagnostic and monitoring tools. Traditional clinical scales are often subjective and insensitive to early changes, complicating trial designs and patient management. Digital health technologies offer a promising avenue for capturing objective biomarkers.

Data Highlights

MeasurePerformance
Combined FeaturesBaseline AUC
Disease-stage Specific FeaturesΔAUC = 0.15
Progression DetectionΔCohen's d = 0.72

Key Findings

  • Digital health technology measures can differentiate early-stage PD from healthy controls.
  • Some measures are effective for initial diagnosis but not for tracking progression, and vice versa.
  • Models using disease-stage specific features show improved performance in detecting progression.
  • Longitudinal changes can be captured more effectively with DHT compared to conventional scales.

Clinical Implications

The study discusses the potential for integrating digital health technologies into clinical practice to improve diagnostic accuracy and monitoring of early Parkinson's disease.

Conclusion

Aligning digital biomarker design with disease stage and clinical objectives is crucial for improving diagnosis and monitoring in Parkinson's disease.

Related Resources & Content

  1. npj Digital Medicine, 2025 -- Multimodal brain network topology and enhanced computer-aided diagnosis in Parkinson’s Disease: a systematic review and meta-analysis
  2. npj Digital Medicine, 2026 -- Smartphone videos are a scalable tool for gait evaluation in Parkinson’s disease
  3. npj Digital Medicine, 2026 -- Innovative Remote Evaluation of Motor and Cognitive Functions in Parkinson's Disease: Utilizing Large Datasets, Machine Learning, and Telehealth Solutions
  4. Concept paper on the need for revision of the guideline on clinical investigation of medicinal products in the treatment of Parkinson’s disease
  5. npj Parkinson's Disease, 2026 -- Wearable-sensor based walking and non-walking measures as progression markers in early to mid-stage Parkinson’s disease
  6. npj Digital Medicine — Smartphone-based prediction of dopaminergic deficit in prodromal and manifest Parkinson’s disease
  7. Concept paper on the need for revision of the guideline on clinical investigation of medicinal products in the treatment of Parkinson’s disease
  8. Wearable-sensor based walking and non-walking measures as progression markers in early to mid-stage Parkinson’s disease | npj Parkinson's Disease
  9. Digital Technologies for Symptom Monitoring in Parkinson Disease | Current Neurology and Neuroscience Reports | Springer Nature Link

Original Source(s)

Stage-specific digital health technology biomarkers enhance diagnostic and early progression detection in Parkinson’s disease

  • by Matthew D. Czech, Samantha Sawicki, Cindy Zadikoff, Chengcheng Liu, Weining Robieson, Ying Liu, Weihua Shi, Jie Shen, Michelle Crouthamel, Maria S. Quinton, Josh Cosman, E. Ray Dorsey, Jamie L. Adams, Naomi Nevler

  • July 8, 2026

Related Content

Second-order morphometric similarity networks predict response to transcutaneous auricular vagus nerve stimulation in major depressive disorder: a two-center study

A preliminary study on brain functional magnetic resonance imaging in migraine patients with visual aura using visual stimulation

Prevalence of cognitive frailty in older adults with stroke in China: a systematic review and meta-analysis